Literature DB >> 14326081

ANTIMICROBIAL ACTIVITY OF KASUGAMYCIN.

M HAMADA, T HASHIMOTO, T TAKAHASHI, S YOKOYAMA, M MIYAKE, T TAKEUCHI, Y OKAMI, H UMEZAWA.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS; BACILLUS; EXPERIMENTAL LAB STUDY; KLEBSIELLA; PHARMACOLOGY; PROTEUS; PSEUDOMONAS; SALMONELLA; STREPTOCOCCUS

Mesh：

Substances：

Year:  1965        PMID： 14326081

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  6 in total

1.  Improvement of kasugamycin-producing strain by the agar piece method and the prototroph method.

Authors:  T Ichikawa; M Date; T Ishikura; A Ozaki
Journal:  Folia Microbiol (Praha)       Date:  1971       Impact factor: 2.099

2.  Kasugamycin-resistant mutants of Bacillus subtilis.

Authors:  A Tominaga; Y Kobayashi
Journal:  J Bacteriol       Date:  1978-09       Impact factor: 3.490

3.  Kasugamycin Is a Novel Chitinase 1 Inhibitor with Strong Antifibrotic Effects on Pulmonary Fibrosis.

Authors:  Jae-Hyun Lee; Chang-Min Lee; Joyce H Lee; Mun-Ock Kim; Jin Wook Park; Suchitra Kamle; Bedia Akosman; Erica L Herzog; Xue Yan Peng; Jack A Elias; Chun Geun Lee
Journal:  Am J Respir Cell Mol Biol       Date:  2022-09       Impact factor: 7.748

4.  In vitro antibacterial activity of kasugamycin.

Authors:  A A Levitan
Journal:  Appl Microbiol       Date:  1967-07

5.  ksgA mutations confer resistance to kasugamycin in Neisseria gonorrhoeae.

Authors:  Paul M Duffin; H Steven Seifert
Journal:  Int J Antimicrob Agents       Date:  2008-12-18       Impact factor: 5.283

6.  The context of the ribosome binding site in mRNAs defines specificity of action of kasugamycin, an inhibitor of translation initiation.

Authors:  Yan Zhang; Nikolay A Aleksashin; Dorota Klepacki; Caleb Anderson; Nora Vázquez-Laslop; Carol A Gross; Alexander S Mankin
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-25       Impact factor: 11.205
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.